Gastric Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastric Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma [Phase 2]
A randomized Phase II trial comparing neoadjuvant chemotherapy to chemoradiotherapy in gastric adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Study of the Apatinib Combine With POF Versus POF in Gastric Cancer [Phase 2]
Phase 2 trial evaluating apatinib in combination with POF versus POF in gastric cancer.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection [Phase 3]
Phase III trial comparing perioperative SOX versus XELOX or SOX alone as post-operative chemotherapy in locally advanced gastric adenocarcin…
-
CLINICAL_TRIALS trial_result · 2019-06-19Clinical Trial Update: S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites [Phase 2]
Phase 2 clinical trial comparing S1 + paclitaxel + bevacizumab vs S1 + oxaliplatin as first-line therapy for metastatic gastric adenocarcino…
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: Adujvant CT+CRT vs Adujvant CT After D2 Resection for Locally Advanced Proximal Gastric Adenocarcinoma [Phase 3]
Phase 3 trial comparing adjuvant chemotherapy plus chemoradiation versus adjuvant chemotherapy after D2 resection in locally advanced proxim…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-05-20Clinical Trial Update: Single-arm Study of Selumetinib in Combination With Docetaxel, in Advanced Gastric Adenocarcinoma Patients With Low/High MEK Signature, RAS Mutation or RAS Amplification as a Second-line Chemotherapy [Phase 2]
Phase 2 single-arm trial evaluating selumetinib with docetaxel in advanced gastric adenocarcinoma patients with MEK signature or RAS alterat…
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: Apatinib Combined With POF for Second-line Treatment of Gastric Adenocarcinoma [Phase 2]
Phase 2 trial evaluating apatinib combined with polypeptide- or POF for second-line treatment in gastric adenocarcinoma.
-
FDA approval · 2019-03-11FDA Approved: TRAZIMERA — Original Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved TRAZIMERA (trastuzumab-qyyP) from Pfizer as an original biologics license application. It is a biosimilar to trastuzumab indica…
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating metronomic capecitabine and docetaxel as second-line chemotherapy for advanced gastric/gastroesophageal ju…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers [Phase 2]
Phase 2 trial assessing CRS-207 with pembrolizumab in gastric, gastroesophageal junction, and esophageal adenocarcinomas; study terminated w…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: A Study of Ramucirumab in Participants With Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial update for ramucirumab in metastatic gastric and gastroesophageal junction adenocarcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer [Phase 2]
Phase 2 trial of ramucirumab with paclitaxel in gastric cancer completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: A Study of Pembrolizumab (MK-3475) Versus Paclitaxel for Participants With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma That Progressed After Therapy With Platinum and Fluoropyrimidine (MK-3475-061/KEYNOTE-061) [Phase 3]
Phase 3 trial comparing pembrolizumab to paclitaxel in advanced gastric/GEJ adenocarcinoma after platinum/fluoropyrimidine showed completed …
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Study of the Combination of Apatinib and POF [Phase 2]
Phase 2 clinical trial update on the combination of Apatinib and POF for gastric adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2018-10-01Clinical Trial Update: Compare Neoadjuvant Chemotherapy of DOS Versus SOX in Locally Advanced Gastric Adenocarcinoma. [Phase 2, Phase 3]
Clinical trial comparing neoadjuvant DOS versus SOX in locally advanced gastric adenocarcinoma (Phase 2/3). Status unknown.
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma [Phase 1, Phase 2]
A phase 1/2 clinical trial investigating XELOX chemotherapy with apatinib as postoperative treatment for locally advanced gastric adenocarci…
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer [Phase 3]
Phase 3 trial of ramucirumab with capecitabine and cisplatin in metastatic gastric/GEJ adenocarcinoma completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma [Phase 2]
Phase II trial of cabazitaxel for refractory metastatic gastric adenocarcinoma and gastroesophageal adenocarcinoma completed; results were p…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: mDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA) [Phase 2]
Phase 2 trial update evaluating the combination of modified DCF chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) with Avelumab in res…
-
CLINICAL_TRIALS research · 2018-03-12Clinical Trial Update: Clinical Study of CAR-CLD18 T Cells in Patients With Advanced Gastric Adenocarcinoma and Pancreatic Adenocarcinoma [NA]
Clinical trial update on CAR-CLD18 T cells for advanced gastric adenocarcinoma and pancreatic adenocarcinoma; current trial status is unknow…
-
CLINICAL_TRIALS withdrawal · 2018-03-12Clinical Trial Update: Density of Neurons in the Stomach and Prognosis of Gastric Adenocarcinoma [NA]
The clinical trial NCT01821196 evaluating neuronal density in the stomach and prognosis of gastric adenocarcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Resilience and Exercise in Advanced Cancer Treatment [NA]
The clinical trial evaluating resilience and exercise in advanced cancer has completed, involving pancreatic adenocarcinoma, gastric adenoca…
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial evaluating pralatrexate and oxaliplatin in unresectable or metastatic esophageal, stomach, or gastroesophageal juncti…
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction [Phase 2]
Phase 2 trial results evaluating irinotecan in combination with cisplatin for patients undergoing surgery for locally advanced gastric or ga…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors [Phase 2]
Phase 2 trial of AMG 337 in MET-amplified gastric and esophageal adenocarcinoma and other solid tumors has been terminated.